153 related articles for article (PubMed ID: 17267639)
1. Hetero-vancomycin-intermediate methicillin-resistant Staphylococcus aureus isolate from a medical center in Las Cruces, New Mexico.
Delgado A; Riordan JT; Lamichhane-Khadka R; Winnett DC; Jimenez J; Robinson K; O'Brien FG; Cantore SA; Gustafson JE
J Clin Microbiol; 2007 Apr; 45(4):1325-9. PubMed ID: 17267639
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.
Chua T; Moore CL; Perri MB; Donabedian SM; Masch W; Vager D; Davis SL; Lulek K; Zimnicki B; Zervos MJ
J Clin Microbiol; 2008 Jul; 46(7):2345-52. PubMed ID: 18508934
[TBL] [Abstract][Full Text] [Related]
3. Survey of methicillin-resistant Staphylococcus aureus strains from two hospitals in El Paso, Texas.
O'Brien FG; Lim TT; Winnett DC; Coombs GW; Pearson JC; Delgado A; Langevin MJ; Cantore SA; Gonzalez L; Gustafson JE
J Clin Microbiol; 2005 Jun; 43(6):2969-72. PubMed ID: 15956434
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
Saravolatz LD; Pawlak J; Johnson LB
Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China.
Wu D; Wang Q; Yang Y; Geng W; Wang Q; Yu S; Yao K; Yuan L; Shen X
Diagn Microbiol Infect Dis; 2010 May; 67(1):1-8. PubMed ID: 20227225
[TBL] [Abstract][Full Text] [Related]
6. In vivo detection of clonally derived methicillin-resistant/methicillin-susceptible Staphylococcus aureus strains is not a rare event.
Francois P; Uckay I; Iten A; Renzi G; Dahran S; Camus V; Sax H; Schrenzel J
J Clin Microbiol; 2008 May; 46(5):1890-1. PubMed ID: 18353932
[No Abstract] [Full Text] [Related]
7. Identification of the first vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolate from a hospital in Portugal.
Gardete S; Aires-De-Sousa M; Faustino A; Ludovice AM; de Lencastre H
Microb Drug Resist; 2008 Mar; 14(1):1-6. PubMed ID: 18346009
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital.
Marchese A; Balistreri G; Tonoli E; Debbia EA; Schito GC
J Clin Microbiol; 2000 Feb; 38(2):866-9. PubMed ID: 10655401
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of European community-associated methicillin-resistant Staphylococcus aureus clonal complex 80 type IV strains isolated in Denmark from 1993 to 2004.
Larsen AR; Böcher S; Stegger M; Goering R; Pallesen LV; Skov R
J Clin Microbiol; 2008 Jan; 46(1):62-8. PubMed ID: 17989197
[TBL] [Abstract][Full Text] [Related]
10. Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate staphylococcus aureus isolates from patients with septic arthritis.
Wang WY; Lee SY; Chiueh TS; Lu JJ
J Clin Microbiol; 2009 Nov; 47(11):3617-23. PubMed ID: 19759226
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Majorcan hospitals: high prevalence of the epidemic clone EMRSA-15.
Alcoceba E; Mena A; Cruz Pérez M; Ruiz de Gopegui E; Padilla E; Gil J; Ramírez A; Gallegos C; Serra A; Pérez JL; Oliver A
Clin Microbiol Infect; 2007 Jun; 13(6):599-605. PubMed ID: 17378930
[TBL] [Abstract][Full Text] [Related]
12. Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.
Ike Y; Arakawa Y; Ma X; Tatewaki K; Nagasawa M; Tomita H; Tanimoto K; Fujimoto S
J Clin Microbiol; 2001 Dec; 39(12):4445-51. PubMed ID: 11724859
[TBL] [Abstract][Full Text] [Related]
13. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center.
Han LL; McDougal LK; Gorwitz RJ; Mayer KH; Patel JB; Sennott JM; Fontana JL
J Clin Microbiol; 2007 Apr; 45(4):1350-2. PubMed ID: 17287335
[TBL] [Abstract][Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan.
Hanaki H; Hososaka Y; Yanagisawa C; Otsuka Y; Nagasawa Z; Nakae T; Sunakawa K
J Infect Chemother; 2007 Apr; 13(2):118-21. PubMed ID: 17458681
[TBL] [Abstract][Full Text] [Related]
16. Investigation of methicillin-resistant Staphylococcus aureus showing reduced vancomycin susceptibility isolated from a patient with infective endocarditis.
Takayama Y; Hanaki H; Irinoda K; Kokubun H; Yoshida K; Sunakawa K
Int J Antimicrob Agents; 2003 Dec; 22(6):567-73. PubMed ID: 14659653
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
Saravolatz LD; Pawlak J; Johnson LB; Saravolatz LD; Husain N
Int J Antimicrob Agents; 2010 Nov; 36(5):478-80. PubMed ID: 20846830
[No Abstract] [Full Text] [Related]
18. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children.
Carrillo-Marquez MA; Hulten KG; Mason EO; Kaplan SL
Pediatr Infect Dis J; 2010 May; 29(5):410-4. PubMed ID: 20431380
[TBL] [Abstract][Full Text] [Related]
19. SCCmec and spa types of methicillin-resistant Staphylococcus aureus strains in Israel. Detection of SCCmec type V.
Chmelnitsky I; Navon-Venezia S; Leavit A; Somekh E; Regev-Yochai G; Chowers M; Shitrit P; Carmeli Y
Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):385-90. PubMed ID: 18074160
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
